The recent instability in global supply have highlighted the importance of securing essential medications like Ivermectin. Relying on overseas manufacturers exposes countries to considerable vulnerabilities, including shipping delays, cost fluctuations, and even political risks. Moving towards domestic production of Ivermectin offers a multitude of